NFIC (Nuclear Factor I C) is a sequence-specific DNA-binding transcription factor that recognizes palindromic sequences in promoters and regulatory regions to modulate gene expression across diverse biological processes. As a transcriptional regulator of RNA polymerase II, NFIC activates or represses target genes through chr19-based mechanisms, often functioning as a co-factor with other transcriptional regulators 1. Mechanistically, NFIC operates in several integrated pathways. In adipogenesis, NFIC recruits the histone demethylase JMJD1A to chr19 at metabolic genes including Pparg, enabling carbohydrate-responsive gene expression through nutrient-sensitive epigenetic remodeling 1. In pancreatic development, NFIC interacts with NR5A2 to regulate acinar gene expression and ribosomal biology while restraining endoplasmic reticulum stress 2. NFIC also participates in transcriptional networks involving FOXA1, C/EBPβ, and other factors regulating cell identity and therapeutic resistance 3, 4. Clinically, NFIC dysregulation associates with multiple malignancies. NFIC is elevated in gastric cancer where it promotes cell proliferation and migration; miR-9-5p suppresses these phenotypes by targeting NFIC 5. Low NFIC expression occurs in pancreatic ductal adenocarcinoma and predisposes to Kras-driven transformation 2. In non-small cell lung cancer, NFIC binding polymorphisms (rs822336) modulate PD-L1 expression and predict immunotherapy response 3. Developmentally, NFIC is essential for dentinogenesis, with mutations causing dentin dysplasia-like phenotypes 6.